Premier issue, June 2017
Parsippany – March 7, 2017 – Frontline Oncology, a division of Frontline Medical Communications (FMC), is pleased to announce the launch of The Sarcoma Journal™. This specialized oncology journal – and affiliated essential resources – is being developed in collaboration with a leading patient advocacy group, the Sarcoma Foundation of America (SFA).
As part of Frontline Oncology’s initiative – Closing the Loop on the Cancer Care Conversation™ – FMC introduces this high-quality, clinical and educational journal, focused on sarcomas, to keep physicians completely informed in their diagnosis and treatment efforts. The journal will be published quarterly, premiering in June, followed by September and December, 2017.
Frank Iorio, Managing Director at Frontline Oncology, announced the launch and said, “We look forward to expanding our communication programs to engage all stakeholders involved in the screening, early detection, and care of patients with sarcomas and to supporting the mission of the Sarcoma Foundation of America.”
As a leader in medical publishing, FMC offers extensive marketing options designed to meet our clients’ specific goals and objectives. For opportunities, contact Frank Iorio at firstname.lastname@example.org or 973.206.8990.
About The Sarcoma Journal™
The Sarcoma Journal™ – Official Journal of the Sarcoma Foundation of America (SFA), www.curesarcoma.org, a leading sarcoma patient advocacy organization, is a conduit to inform and educate physicians and allied healthcare professionals (HCPs) on the latest research and leading treatments for soft/connective-tissue tumors. Published quarterly by Frontline Oncology, The Sarcoma Journal™ (www.sarcomajournal.org) addresses the needs of oncologists, pediatric oncologists and other HCPs treating sarcomas by providing professional resources covering the most current medical news, diagnosis and treatment information on these cancer types. The journal supports the SFA’s activities focused on funding research, increasing awareness, and providing information on clinical trials throughout the U.S. By facilitating communication among the medical and scientific community, The Sarcoma Journal™ seeks to support early detection, patient education, and more rapid developments of new and better sarcoma treatments, as part of the continuum of care.
About Frontline Oncology:
Frontline Oncology develops and produces communications that deliver high-quality medical news and clinical diagnostic and therapeutic information for oncologists, hematologists, and other health care professionals involved in evaluating and treating patients with cancer and blood related conditions. Print and digital brands include OncologyPractice.com™; Journal of Community & Supportive Oncology, a peer-reviewed on-line journal that features Original Research and Review articles, Case Reports, and How We Do It essays in clinical oncology and supportive care ; Hematology News®, presenting the latest news, views and commentary on blood diseases and disorders; and, in partnership with Hematology Times™, the online resource offering scientific research on hematologic conditions including KOL commentary, articles, and CME.
About Frontline Medical Communications:
Frontline Medical Communications Inc. is one of the healthcare industry’s largest medical communications companies and a leader in digital, print, and live events. The Company leads in HCP-level targeting and is ranked 1st in combined web and print engagements. With the launch of MDedge™, our state-of-the-art integrated web portal, and audited database, FMC meets the marketing challenges of our clients with superior reach, optimal sponsorship opportunities, and flexible advertising programs. We reach 1.2 million+ physicians, NPs, PAs, and other HCPs through more than 30 media brands serving 22 distinct markets. Print reach surpasses 800,000 and extends digitally with newsletters, interactive Web sites, mobile apps and digital editions. FMC delivers indexed and clinical review articles and medical news daily from on-site reporting at major medical meetings; many in collaboration with notable societies and medical associations. FMC produces live events and digital click-for-credit CME through affiliation with Global Academy for Medical Education, LLC (globalacademycme.com).
Frank Iorio, Managing Director, Frontline Oncology, 973.206.8990, email@example.com
Corporate office: 7 Century Drive, Suite 302|Parsippany, NJ 07054-4609|Main: 973.206.3434|Fax: 973.206.9378
www.frontlinemedcom.com | www.frontlinerates.com | General Email: firstname.lastname@example.org